These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3226448)

  • 1. The therapeutic potential of plasmapheresis in systemic lupus erythematosus (SLE).
    Swaak AJ
    Neth J Med; 1988 Oct; 33(3-4):155-9. PubMed ID: 3226448
    [No Abstract]   [Full Text] [Related]  

  • 2. [Status of plasmapheresis and cyclosporin A in the treatment of systemic lupus erythematosus].
    Graf N; Bambauer R; Jost W; Schäfer M
    Monatsschr Kinderheilkd; 1990 Jul; 138(7):395-8. PubMed ID: 2398909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lupus erythematosus; current treatment methods].
    Nossent JC
    Ned Tijdschr Geneeskd; 1993 Mar; 137(11):558. PubMed ID: 8464532
    [No Abstract]   [Full Text] [Related]  

  • 4. [Systemic lupus erythematosus].
    Schröder JO; Euler HH
    Internist (Berl); 1993 Apr; 34(4):351-61. PubMed ID: 8486478
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasmapheresis for lupus nephritis.
    Robinson JA
    N Engl J Med; 1992 Oct; 327(14):1028-9; author reply 1029-30. PubMed ID: 1472252
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasmapheresis combined with pharmacology in the treatment of lupus nephritis: a new therapeutic protocol].
    Russo GE; Bonello M; Vitaliano E; Bosco M; Maresca L; De Paola A; Tedaldi M; Bisciglia MF; Bauco B
    Clin Ter; 2000; 151(1):9-13. PubMed ID: 10822875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synchronizing therapy with plasmapheresis and cyclophosphamide in rapidly progressing systemic lupus erythematosis with kidney involvement].
    Demin AA; Sentiakova TN; Smirnov VV; Demina LM; Mamin IV
    Ter Arkh; 1996; 68(5):27-30. PubMed ID: 9082593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of patients with systemic lupus erythematosus complicated with autoimmune thyroid disease using double-filtration plasmapheresis: a retrospective study.
    Liu LL; Li XL; Wang LN; Yao L; Fan QL; Li ZL
    J Clin Apher; 2011; 26(4):174-80. PubMed ID: 21462239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmapheresis therapy is ineffective in SLE. Lupus Nephritis Collaborative Study Group.
    Lewis EJ
    J Clin Apher; 1992; 7(3):153. PubMed ID: 1286995
    [No Abstract]   [Full Text] [Related]  

  • 10. Idiotypic vaccination with a murine anti-dsDNA antibody: phase I study in patients with nonactive systemic lupus erythematosus with nephritis.
    Spertini F; Leimgruber A; Morel B; Khazaeli MB; Yamamoto K; Dayer JM; Weisbart RH; Lee ML
    J Rheumatol; 1999 Dec; 26(12):2602-8. PubMed ID: 10606369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmapheresis in the treatment of systemic lupus erythematosus.
    Błaszczyk M; Chorzelski T; Daszyński J; Gaczkowski A; Jabłońska S; Beutner EH
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):769-72. PubMed ID: 6983871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options in lupus nephritis.
    McLigeyo SO
    East Afr Med J; 1998 Oct; 75(10):609-13. PubMed ID: 10065198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apheresis for lupus erythematosus.
    Wallace DJ
    Lupus; 1999; 8(3):174-80. PubMed ID: 10342709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis.
    Danieli MG; Palmieri C; Salvi A; Refe MC; Strusi AS; Danieli G
    J Clin Apher; 2002; 17(2):72-7. PubMed ID: 12210709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare cost and loss of productivity in a Canadian population of patients with and without lupus nephritis.
    Aghdassi E; Zhang W; St-Pierre Y; Clarke AE; Morrison S; Peeva V; Landolt-Marticorena C; Su J; Reich H; Scholey J; Herzenberg A; Pope JE; Peschken C; ; Wither JE; Fortin PR
    J Rheumatol; 2011 Apr; 38(4):658-66. PubMed ID: 21159829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of systemic lupus erythematosus.
    Miller ML
    Curr Opin Rheumatol; 1991 Oct; 3(5):803-8. PubMed ID: 1751312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selected aspects of therapy of systemic lupus erythematosus].
    Hiepe F; Apostoloff E
    Z Arztl Fortbild (Jena); 1992 Apr; 86(7-8):383-7. PubMed ID: 1615720
    [No Abstract]   [Full Text] [Related]  

  • 18. [New perspectives in the classification and treatment of systemic lupus erythematosus: the central role of kidney involvement].
    Cavagna L; Scorletti E; Romano M; Cagnotto G; Caporali R
    G Ital Nefrol; 2013; 30(4):. PubMed ID: 24403199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmapheresis and subsequent pulse cyclophosphamide in severe systemic lupus erythematosus. An interim report of the Lupus Plasmapheresis Study Group.
    Euler HH; Guillevin L
    Ann Med Interne (Paris); 1994; 145(5):296-302. PubMed ID: 7985935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
    Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S
    Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.